We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Truist Financial
TFC
$63.4B
| $650K | ﹤0.01% |
14,973
-1,974
| -12% | -$88.1K |
|
|
SMAR
452
DELISTED
Smartsheet Inc.
SMAR
| $634K | ﹤0.01% |
11,312
| – | – |
|
453
PG&E
PCG
$37.5B
| $618K | ﹤0.01% |
+30,645
| New | +$623K |
|
454
Pilgrim's Pride
PPC
$6.31B
| $594K | ﹤0.01% |
13,079
| – | – |
|
455
Mine Safety
MSA
$7.45B
| $586K | ﹤0.01% |
3,536
| – | – |
|
456
Ameriprise Financial
AMP
$49.2B
| $576K | ﹤0.01% |
1,082
| – | – |
|
457
Owens Corning
OC
$12.2B
| $512K | ﹤0.01% |
3,007
-87
| -3% | -$16.3K |
|
458
Hyatt Hotels
H
$16B
| $489K | ﹤0.01% |
3,116
| – | – |
|
459
Vanguard Total World Stock ETF
VT
$81.2B
| $456K | ﹤0.01% |
3,882
+2,695
| +227% | +$323K |
|
460
Devon Energy
DVN
$49.9B
| $424K | ﹤0.01% |
12,965
-1,356
| -9% | -$51.1K |
|
461
Battalion Oil
BATL
$31M
| $423K | ﹤0.01% |
245,548
-5,320
| -2% | -$25.9K |
|
462
iShares MSCI India ETF
INDA
$6.6B
| $419K | ﹤0.01% |
7,951
+949
| +14% | +$52.3K |
|
463
WisdomTree India Earnings Fund ETF
EPI
$2.05B
| $418K | ﹤0.01% |
9,231
+1,095
| +13% | +$51.9K |
|
464
Datadog
DDOG
$93.6B
| $414K | ﹤0.01% |
2,900
| – | – |
|
465
Brixmor Property Group
BRX
$9.15B
| $393K | ﹤0.01% |
14,132
| – | – |
|
466
Cisco
CSCO
$483B
| $343K | ﹤0.01% |
5,791
-648
| -10% | -$37K |
|
467
HDFC Bank
HDB
$120B
| $325K | ﹤0.01% |
10,194
| – | – |
|
468
Berkshire Hathaway Class B
BRK.B
$1.14T
| $278K | ﹤0.01% |
614
+129
| +27% | +$59.6K |
|
469
Chevron
CVX
$382B
| $268K | ﹤0.01% |
1,852
-561
| -23% | -$85.9K |
|
470
McDonald's
MCD
$194B
| $267K | ﹤0.01% |
922
-131
| -12% | -$39.1K |
|
471
iShares Core US Aggregate Bond ETF
AGG
$137B
| $264K | ﹤0.01% |
2,723
+643
| +31% | +$63.3K |
|
472
Vanguard S&P 500 ETF
VOO
$1.03T
| $259K | ﹤0.01% |
480
-195
| -29% | -$106K |
|
473
IBM
IBM
$223B
| $250K | ﹤0.01% |
1,138
-275
| -19% | -$61.2K |
|
474
PepsiCo
PEP
$188B
| $245K | ﹤0.01% |
1,612
-353
| -18% | -$57.8K |
|
475
Vanguard Russell 2000 ETF
VTWO
$17.3B
| $242K | ﹤0.01% |
2,713
+970
| +56% | +$89.5K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.